Michelle Gong, MD
Pulmonary Disease · New York, NYNPI 1114946233
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $4,834 of the $7,174 with a category attached, or 67.4%. 4 manufacturers reported payments, led by Philips North America LLC at 32.8% of the total. 2024 is the largest year on record at $4,364, 3.1 times the $1,400 reported in 2021.
Across 7 payments — averaging $1024.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Philips North America LLC$2K
- Regeneron$2K
- Life Technologies Corporation$1K
- Radiometer America, Inc$1K
Across 19 payments — averaging $30,803 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$566K
- Amgen$18K
- Omeros Corporation$870
- Takeda Pharmaceuticals U.S.A., Inc.$786
What the payments were for
- Consulting fees$4,83467%
- Speaking & faculty fees$2,34033%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Philips North America LLC | 2 | $2,350 |
| Regeneron | 3 | $2,244 |
| Life Technologies Corporation | 1 | $1,400 |
| Radiometer America, Inc | 1 | $1,180 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Respiratory$2,350
How this compares
$7,174 in reported general payments places this provider in the 75th percentile of 1,115 pulmonary disease providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in New York
- Charles PowellNew York$654K
- Bisher AkilNew York$480K
- Sonali SethiNew York$388K
- Johnathan RaskinNew York$338K
- Monica KraftNew York$247K
- Jamie BessichNew York$226K
- Ronald CrystalNew York$213K
- Michael NiedermanNew York$176K
- Wilfredo TalaveraNew York$145K
- Josanna Rodriguez-LopezNew York$128K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.